Publications

This clinical advice from the BreastScreen Australia (BSA) reviews the role of screening services in reporting implant problems detected during screening.

This fact sheet from the Environmental Health Standing Committee (enHealth) provides information about fluorinated chemicals.

This A3-sized poster encourages women over 50 to have a free breast screen.

This guide outlines issues that Primary Health Networks (PHNs) are likely to need to address in a commissioning environment. Primary Health Network (PHN) plans consider the needs, opportunities, priorities and options identified in PHN needs assessments.

This resource document supports the Primary Health Networks (PHNs) – Planning in a commissioning environment guide. It identifies some resources that may be useful to PHNs in addressing any issues they might face in a commissioning environment.

This document outlines the Medical Benefits Schedule (MBS) Taskforce’s recommendations relating to consultation on obsolete MBS items undertaken in 2015.

This report summarises the results of the outcomes of the Evaluation of the National External Breast Prostheses Reimbursement Programme.

This document provides Primary Health Networks (PHNs) with guidance on assessing, planning and commissioning suicide prevention services. It outlines best-practice strategies to reduce suicide.

Roy Morgan survey data was analysed to determine the effect of tobacco plain packaging legislation. The report found that there were fewer smokers after the legislation was introduced.

Australian Government response to the Senate Community Affairs References Committee report: Palliative Care in Australia.

The Health Portfolio Budget Statements for the 2016 to 2017 financial year outline how the Government has allocated resources to outcomes for all entities within our portfolio.

Australian Government response to the review of medicines and medical devices regulation

This guide is intended to provide general information about aged care places management.

This report outlines an analysis of the anaesthesia workforce and the results of updated supply and demand projections, as well as considering capacity and distribution for vocational training into the future. It is part of our series on Australia’s Future Health Workforce.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for Clostridium perfringens enteritis.

This page contains information on the National Strategic Framework for Rural and Remote Health.

The framework was developed in partnership with states and territories.

This document recognises the commitment by Primary Health Networks (PHNs) and Aboriginal Community Controlled Health Organisations (ACCHOs) to work together to improve access to health services and improve health outcomes for Aboriginal and Torres Strait Islander people.

This document contains the surveillance case definition for hepatitis A, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

BreastScreen Australia services and State Coordination Units (SCUs) use this form to respond to issues identified in the Survey and Interim Survey Report and NAS Measures that are unmet, unable to be assessed or met with exception. It must be submitted as part of an application for accreditation.

The Australian Government based the Australian National Diabetes Strategy 2016–2020 on the framework provided in this report.

The Public Health and Chronic Disease Grant program started on 1 July 2016. These guidelines outline the types of activities that this program funds, and how they are administered.

This report outlines an analysis of the psychiatry workforce and the results of updated supply and demand projections, as well as considering capacity and distribution for vocational training into the future. It is part of our series on Australia’s Future Health Workforce.

This fact sheet contains the list of security sensitive biological agents (SSBAs) that we regulate in Australia.

This document sets out the principles that proposals had to address when applying for Pharmacy Trial Program grants.